NIH #5R21CA209533-02
Candidate Gene Resequencing of Germline Multiple Myeloma
- Amount
- $187K
- Period
- 2017-09-01 → 2020-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SLOAN-KETTERING INST CAN RESEARCH
BRCA gene mutations in cancer · Genetics
4 total · 0 active
NIH #5R21CA209533-02
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #1R21CA209533-01A1
Awarded at SLOAN-KETTERING INST CAN RESEARCH
NIH #5R21CA178800-02
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers
medRxiv · 2026-06-22
2025-12-17
2025-12-17
2025-12-17
2025-12-17
2025-12-17
Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025-11-26
Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025-11-26
Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025-11-26
2025-11-26
2025-11-26
2025-11-26
2025-11-25
2025-11-25
2025-11-25
2025-11-25
2025-11-25
2025-11-25
2025-11-25
2025-11-25